{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T17:44:57Z","timestamp":1648662297577},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2001,1,1]],"date-time":"2001-01-01T00:00:00Z","timestamp":978307200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"published-print":{"date-parts":[[2001,1]]},"DOI":"10.1007\/s11886-001-0015-z","type":"journal-article","created":{"date-parts":[[2007,5,26]],"date-time":"2007-05-26T08:53:19Z","timestamp":1180169599000},"page":"85-89","source":"Crossref","is-referenced-by-count":2,"title":["Antithrombotic therapy for prosthetic valves: Routine treatment and special considerations"],"prefix":"10.1007","volume":"3","author":[{"given":"Amin M.","family":"Al-Ahmad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denise","family":"Hartnett-Daudelin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deeb N.","family":"Salem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"15_CR1","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1056\/NEJM199608083350607","volume":"335","author":"W Vongpatanasin","year":"1996","unstructured":"Vongpatanasin W, Hillis DL, Lange RA: Medical progress: prosthetic heart valves. N Engl J Med 1996, 335:407\u2013416.","journal-title":"N Engl J Med"},{"key":"15_CR2","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1161\/01.CIR.98.18.1949","volume":"98","author":"RO Bonow","year":"1998","unstructured":"Bonow RO, Carabello B, de Leaon AC Jr, et al.: ACC\/AHA guidelines for the management of patients with valvular heart disease: executive summary. A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease). Circulation 1998, 98:1949\u20131984. This paper contains the American Heart Association\/American College of Cardiology guidelines for anticoagulation in patients with prosthetic heart valves, as well as guidelines on anticoagulation.","journal-title":"Circulation"},{"key":"15_CR3","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0025-6196(11)64893-3","volume":"73","author":"DJ Tiede","year":"1998","unstructured":"Tiede DJ, Nishimura RA, Gastineau DA, et al.: Modern management of prosthetic valve anticoagulation. Mayo Clin Proc 1998, 73:665\u2013680.","journal-title":"Mayo Clin Proc"},{"key":"15_CR4","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1161\/01.CIR.89.2.635","volume":"89","author":"SC Cannegieter","year":"1994","unstructured":"Cannegieter SC, Rosendaal FR, Briet E: Thromboembolic and bleeding complications in patients with mechanical heart valves. Circulation 1994, 89:635\u2013641.","journal-title":"Circulation"},{"key":"15_CR5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJM199507063330103","volume":"333","author":"SC Cannegieter","year":"1995","unstructured":"Cannegieter SC, Rosendaal FR, Wintzen AR, et al.: Optimal oral anticoagulant therapy in patients with mechanical heart valves. N Engl J Med 1995, 333:11\u201317.","journal-title":"N Engl J Med"},{"key":"15_CR6","doi-asserted-by":"crossref","first-page":"I70","DOI":"10.1161\/01.CIR.35.4S1.I-70","volume":"35","author":"GE Duvoisin","year":"1967","unstructured":"Duvoisin GE, Brandenberg RO, McGoon DC: Factors affecting thromboembolism associated with prosthetic heart valves. Circulation 1967, 35:I70-I76.","journal-title":"Circulation"},{"key":"15_CR7","first-page":"I77","volume":"35","author":"TJ Yeh","year":"1967","unstructured":"Yeh TJ, Anabtawi IN, Cornett VE, et al.: Influence of rhythm and anticoagulation upon the incidence of embolization associated with Starr-Edwards prosthesis. Circulation 1967, 35:I77-I81.","journal-title":"Circulation"},{"key":"15_CR8","first-page":"I157","volume":"66","author":"V Fuster","year":"1982","unstructured":"Fuster V, Pumphrey CW, McGoon MD, et al.: Systemic thromboembolism in mitral and aortic Starr-Edwards prosthesis: A 10- to 19-year follow-up. Circulation 1982, 66(suppl):I157-I161.","journal-title":"Circulation"},{"key":"15_CR9","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1056\/NEJM199002153220703","volume":"322","author":"JN Saour","year":"1990","unstructured":"Saour JN, Sieck JO, Mamo LAR, et al.: Trail of different intensities of anticoagulation in patients with prosthetic heart valves. N Engl J Med 1990, 322:428\u2013432.","journal-title":"N Engl J Med"},{"key":"15_CR10","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0022-5223(19)36724-8","volume":"101","author":"R Altman","year":"1991","unstructured":"Altman R, Sieck JO, Mamo LAR, et al.: Comparison of two levels of anticoagulant therapy in patients with substitute heart valves. J Thorac Cardiovasc Surg 1991, 101:427\u2013431.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"15_CR11","first-page":"291","volume":"2","author":"D Horskotte","year":"1993","unstructured":"Horskotte D, Schulte H, Bricks W, et al.: Unexpected findings concerning thromboembolic complications and anticoagulation after complete 10 year follow up of patients with Sr. Jude Medical prosthesis. J Heart Valve Dis 1993, 2:291\u2013301.","journal-title":"J Heart Valve Dis"},{"key":"15_CR12","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1161\/01.CIR.94.9.2107","volume":"94","author":"J Acar","year":"1996","unstructured":"Acar J, Iung B, Boissel J, and the AREVA Group: AREVA: Multicenter randomized comparison of low-dose versus standard dose anticoagulation in patients with mechanical heart valves. Circulation 1996, 94:2107\u20132112.","journal-title":"Circulation"},{"key":"15_CR13","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1056\/NEJM199507063330112","volume":"333","author":"S Fihn","year":"1995","unstructured":"Fihn S: Aiming for safe anticoagulation. N Engl J Med 1995, 333:54\u201355.","journal-title":"N Engl J Med"},{"key":"15_CR14","first-page":"III61","volume":"84","author":"EG Butchart","year":"1991","unstructured":"Butchart EG, Lewis PA, Bethel JA, et al.: Adjusting Anticoagulation to prosthesis thrombogenicity and patient risk factors. Recommendations for the Medtronic Hall valve. Circulation 1991, 84(suppl): III61-III69.","journal-title":"Circulation"},{"key":"15_CR15","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1161\/01.CIR.94.9.2113","volume":"94","author":"R Altman","year":"1996","unstructured":"Altman R, Rouvier J, Gurfinkel E, et al.: Comparison of highdose with low-dose aspirin in patients with mechanical heart valve replacement treated with oral anticoagulant. Circulation 1996, 94:2113\u20132116.","journal-title":"Circulation"},{"key":"15_CR16","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1056\/NEJM199308193290802","volume":"329","author":"AG Turpie","year":"1993","unstructured":"Turpie AG, Gent M, Laupacis A, et al.: A comparison of aspirin with placebo in patients treated with warfarin after heart valve replacement. N Engl J Med 1993, 329:524\u2013529.","journal-title":"N Engl J Med"},{"key":"15_CR17","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/0002-8703(95)90365-8","volume":"130","author":"JC Cappelleri","year":"1995","unstructured":"Cappelleri JC, Fiore LD, Brophy MT, et al.: Efficacy and safety of combined anticoagulant and antiplatelet therapy versus anticoagulant monotherapy after mechanical heart-valve replacement: a meta-analysis. Am Heart J 1995, 130:547\u2013552.","journal-title":"Am Heart J"},{"key":"15_CR18","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.4065\/72.12.1103","volume":"72","author":"KC Huber","year":"1997","unstructured":"Huber KC, Gersh BJ, Bailey KR, et al.: Variability in anticoagulation control predicts thromboembolism after mechanical cardiac valve replacement: A 23-year population based study. Mayo Clin Proc 1997, 72:1103\u20131110.","journal-title":"Mayo Clin Proc"},{"key":"15_CR19","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s11886-000-0026-1","volume":"2","author":"AM Al-Ahmad","year":"2000","unstructured":"Al-Ahmad AM, Hartnett Daudelin D, Salem DN: Antithrombotic therapy for valve disease: Native and prosthetic valves. Curr Cardiol Report 2000, 2:56\u201360.","journal-title":"Curr Cardiol Report"},{"key":"15_CR20","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/0735-1097(94)00563-6","volume":"25","author":"M Heras","year":"1995","unstructured":"Heras M, Chesebro JH, Fuster V, et al.: High risk of thromboemboli early after bioprosthetic cardiac valve replacement. J Am Coll Cardiol 1995, 25:1111\u20131119.","journal-title":"J Am Coll Cardiol"},{"key":"15_CR21","doi-asserted-by":"crossref","first-page":"511","DOI":"10.7326\/0003-4819-118-7-199304010-00005","volume":"118","author":"SD Fihn","year":"1993","unstructured":"Fihn SD, McDonell MB, Martin D, et al.: Risk factors for complications of chronic anticoagulation: a multicenter study. Ann Intern Med 1993, 118:511\u2013520.","journal-title":"Ann Intern Med"},{"key":"15_CR22","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1365-2796.1991.tb00358.x","volume":"229","author":"J Launbjerg","year":"1991","unstructured":"Launbjerg J, Egeblad H, Heaf J, et al.: Bleeding complications to oral anticoagulant therapy: multivariate analysis of 1010 treatment years in 551 outpatients. J Intern Med 1991, 229:351\u2013355.","journal-title":"J Intern Med"},{"key":"15_CR23","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1161\/01.STR.19.1.124","volume":"19","author":"VL Babikian","year":"1988","unstructured":"Babikian VL, Kase CS, Pessin MS, et al.: Resumption of anticoagulation after intracranial bleeding in patients with prosthetic heart valves [letter]. Stroke 1988, 19:407.","journal-title":"Stroke"},{"key":"15_CR24","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1097\/00006123-199804000-00053","volume":"42","author":"EFM Wijdicks","year":"1998","unstructured":"Wijdicks EFM, Schievink WI, Brown RD, et al.: The dilemma of discontinuation of anticoagulation therapy for patients with intracranial hemorrhage and mechanical heart valves. Neurosurgery 1998, 42:769\u2013773.","journal-title":"Neurosurgery"},{"key":"15_CR25","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1212\/WNL.50.5.1489","volume":"50","author":"RR Leker","year":"1998","unstructured":"Leker RR, Abramsky O: Early anticoagulation in patients with prosthetic heart valves and intracerebral hematoma. Neurology 1998, 50:1489\u20131491.","journal-title":"Neurology"},{"key":"15_CR26","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1046\/j.1365-2141.1998.01078.x","volume":"103","author":"AC Butler","year":"1998","unstructured":"Butler AC, Tait RC: Restarting anticoagulation in prosthetic heart valve patients after intracranial haemorrhage: a 2-year follow-up. Br J Haematol 1998, 103:1064\u20131066.","journal-title":"Br J Haematol"},{"key":"15_CR27","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s11886-000-0029-y","volume":"2","author":"TG DeLoughery","year":"2000","unstructured":"DeLoughery TG: Anticoagulant therapy in special circumstances. Curr Cardiol Report 2000, 2:74\u201379.","journal-title":"Curr Cardiol Report"},{"key":"15_CR28","doi-asserted-by":"crossref","first-page":"814","DOI":"10.7326\/0003-4819-102-6-814","volume":"102","author":"AI Shaper","year":"1985","unstructured":"Shaper AI: The hypercoagulable states. Ann Intern Med 1985, 102:814\u2013828.","journal-title":"Ann Intern Med"},{"key":"15_CR29","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1001\/archinte.160.2.191","volume":"160","author":"WS Chan","year":"2000","unstructured":"Chan WS, Anand S, Ginsberg JS: Anticoagulation of pregnant women with mechanical heart valves: A systemic review of the literature. Arch Intern Med 2000, 160:191\u2013196.","journal-title":"Arch Intern Med"},{"key":"15_CR30","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/S0735-1097(99)00044-3","volume":"33","author":"N Vitale","year":"1999","unstructured":"Vitale N, De Feo M, De Santo LS, et al.: Dose dependent fetal complications of warfarin in pregnant women with mechanical heart valves. J Am Coll Cardiol 1999, 33:1637\u20131641.","journal-title":"J Am Coll Cardiol"},{"key":"15_CR31","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1056\/NEJM198611273152205","volume":"315","author":"I Iurbe-Alessio","year":"1986","unstructured":"Iurbe-Alessio I, Fonseca MC, Mutchinik O, et al.: Risks of anticoagulant therapy in pregnant women with artificial heart valves. N Engl J Med 1986, 315:1390\u20131393.","journal-title":"N Engl J Med"},{"key":"15_CR32","first-page":"I169","volume":"70","author":"E Salazar","year":"1984","unstructured":"Salazar E, Zajarias A, Gutierrez N, et al.: The problem of cardiac valve prosthesis, anticoagulants, and pregnancy. Circulation 1984, 70:I169-I177.","journal-title":"Circulation"},{"key":"15_CR33","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0735-1097(86)80116-4","volume":"8","author":"PK Lee","year":"1986","unstructured":"Lee PK, Wang RY, Chow JS, et al.: Combined use of warfarin and adjusted subcutaneous heparin during pregnancy in patients with an artificial heart valve. J Am Coll Cardiol 1986, 8:221\u2013224.","journal-title":"J Am Coll Cardiol"},{"key":"15_CR34","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1016\/0735-1097(96)00072-1","volume":"27","author":"E Salazar","year":"1996","unstructured":"Salazar E, Izaguirre R, Verdejo J, et al.: Failure of adjusted doses of subcutaneous heparin to prevent thromboembolic phenomena in pregnant patients with mechanical cardiac valve prosthesis. J Am Coll Cardiol 1996, 27:1698\u20131703.","journal-title":"J Am Coll Cardiol"},{"key":"15_CR35","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1471-0528.2000.tb11696.x","volume":"107","author":"L Sadler","year":"2000","unstructured":"Sadler L, McCowan L, White H, et al.: Pregnancy outcomes and cardiac complications in women with mechanical, bioprosthetic and homograft valves. Br J Obstet Gynecol 2000, 107:245\u2013253.","journal-title":"Br J Obstet Gynecol"},{"key":"15_CR36","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0889-8545(05)70319-3","volume":"24","author":"LA Barbour","year":"1997","unstructured":"Barbour LA: Current concepts of anticoagulant therapy in pregnancy. Obstet Gynecol Clin North Am 1997, 24:499\u2013521.","journal-title":"Obstet Gynecol Clin North Am"},{"key":"15_CR37","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1055\/s-0038-1650255","volume":"75","author":"JS Douketis","year":"1996","unstructured":"Douketis JS, Ginsberg JS, Burrows RF, et al.: The effects of long-term heparin therapy during pregnancy on bone density: A prospective matched cohort study. Thromb Haemost 1996, 75:254\u2013257.","journal-title":"Thromb Haemost"},{"key":"15_CR38","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/S0002-9378(94)70299-3","volume":"170","author":"LA Barbour","year":"1994","unstructured":"Barbour LA, Kick SD, Steiner JF, et al.: A prospective study of heparin-induced osteoporosis in pregnancy using bone densitometry. Am J Obstet Gynecol 1994, 170:862\u2013869.","journal-title":"Am J Obstet Gynecol"},{"key":"15_CR39","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1177\/107602969900500202","volume":"5","author":"HL Messmore","year":"1999","unstructured":"Messmore HL, Kundur R, Wehrmacher W, et al.: Anticoagulant therapy of pregnant patients with prosthetic heart valves: rationale for a clinical trial of low molecular weight heparin. Clinical Applied Thrombosis-Hemostasis 1999, 5:73\u201377.","journal-title":"Clinical Applied Thrombosis-Hemostasis"},{"key":"15_CR40","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S0003-4975(99)00874-7","volume":"69","author":"O Lev-Ran","year":"2000","unstructured":"Lev-Ran O, Kramer A, Gurevitch J, et al.: Low-molecular weight heparin for prosthetic heart valves: treatment failure. Ann Thorac Surg 2000, 69:264\u2013265.","journal-title":"Ann Thorac Surg"},{"key":"15_CR41","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1055\/s-0037-1614550","volume":"81","author":"BJ Sanson","year":"1999","unstructured":"Sanson BJ, Lensing AWA, Prins MH, et al.: Safety of low-molecular weight heparin in pregnancy a systemic review. Thromb Haemost 1999, 81:668\u2013672.","journal-title":"Thromb Haemost"},{"issue":"Suppl 5","key":"15_CR42","doi-asserted-by":"crossref","first-page":"602S","DOI":"10.1378\/chest.114.5_Supplement.602S","volume":"114","author":"PD Stein","year":"1998","unstructured":"Stein PD, Alpert JS, Dalen JE, et al.: Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves. Chest 1998, 114(Suppl 5):602S-610S. Guideline paper on anticoagulation in patients with prosthetic heart valves.","journal-title":"Chest"},{"key":"15_CR43","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0002-8703(76)80251-7","volume":"92","author":"RE Katholi","year":"1976","unstructured":"Katholi RE, Nolan SP, McGuire LB: Living with prosthetic heart valves: subsequent noncardiac operations and the risk of thromboembolism or hemorrhage. Am Heart J 1976, 92:163\u2013167.","journal-title":"Am Heart J"},{"key":"15_CR44","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0002-8703(78)90080-7","volume":"96","author":"RE Katholi","year":"1978","unstructured":"Katholi RE, Nolan SP, McGuire LB: The management of anticoagulation during noncardiac operations in patients with prosthetic heart valves: a prospective study. Am Heart J 1978, 96:163\u2013165.","journal-title":"Am Heart J"},{"key":"15_CR45","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1056\/NEJM199705223362107","volume":"336","author":"C Kearon","year":"1997","unstructured":"Kearon C, Hirsh J: Current concepts: Management of anticoagulation before and after elective surgery. N Engl J Med 1997, 336:1506\u20131511.","journal-title":"N Engl J Med"}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-001-0015-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11886-001-0015-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-001-0015-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T11:37:07Z","timestamp":1587555427000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11886-001-0015-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,1]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2001,1]]}},"alternative-id":["15"],"URL":"https:\/\/doi.org\/10.1007\/s11886-001-0015-z","relation":{},"ISSN":["1523-3782","1534-3170"],"issn-type":[{"value":"1523-3782","type":"print"},{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,1]]}}}